Abbott Laboratories (SWX:ABT)
102.00
-2.00 (-1.92%)
Jul 31, 2025, 11:52 PM CET
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 184.42 billion as of September 5, 2025. Its market cap has increased by 9.64% in one year.
Market Cap
184.42B
Enterprise Value
189.56B
Revenue
34.28B
Ranking
n/a
PE Ratio
16.65
Stock Price
102.00
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 184.42B, an increase of 28,883.47%. That is a compound annual growth rate of 10.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 4, 2025 | 186.36B | 4.83% |
Dec 31, 2024 | 177.78B | 10.48% |
Dec 29, 2023 | 160.91B | -9.10% |
Dec 30, 2022 | 177.01B | -19.55% |
Dec 31, 2021 | 220.03B | 32.56% |
Dec 31, 2020 | 165.98B | 11.57% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 225.10B |
Novartis AG | 195.91B |
Lonza Group AG | 39.58B |
Galderma Group AG | 32.57B |
Alcon | 31.15B |
Sandoz Group AG | 21.19B |
Straumann Holding AG | 14.79B |
Sonova Holding AG | 13.66B |